24.09.2024 – 12:25WirtschaftRHEACELL GmbH und Co. KGRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVUmehr
28.02.2024 – 15:00Gesundheit / MedizinRHEACELL GmbH und Co. KGResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘mehr
05.10.2023 – 11:01Deutsche Post DHL Group2PM: KI-gestützte Computer Vision ist laut neuestem DHL Trend Report branchenprägende Technologie / PR: AI-driven computer vision has become an industry-shaping technology, finds latest DHL’s Trend Reportmehr
27.06.2023 – 11:23Gesundheit / MedizinRHEACELL GmbH und Co. KGRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affectedmehr
09.11.2022 – 10:39Gesundheit / MedizinRHEACELL GmbH und Co. KGStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa researchmehr